What is the main business of Celvet?

The main business activity of Celvet focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 21, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Aksamitna 15, 05-870 Błonie.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $1,200, representing an increase of 89.0% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $3,346. For comparison, in 2023 the loss was $6,365, meaning the company reduced its loss by 50.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $4,529 in 2024, representing 100% of all operating expenses.

Celvetsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-07-21

Share capital

5 000,00 PLN

Registered address

ul. Aksamitna 15, 05-870 Błonie, Poland

Website

celvet.eu

Phone

Social media

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 809.14MedianUSD 782.27kAverageUSD 24.03m

Net profit

This companyUSD -1.12kMedianUSD 7.91kAverageUSD 2.59m

Operating costs

This companyUSD 1.92kMedianUSD 723.93kAverageUSD 19.92m

Assets

This companyUSD 1.31kMedianUSD 800.34kAverageUSD 29.11m

News

2019-10-18

Effective and easy-to-administer antibiotic for dogs and cats – CELAMOX in oleogel form

Industry

Bank accounts

Registered as a VAT taxpayer on 2021-08-01. Active

PKO Bank Polski
63 1020 1055 0000 9402 0501 2663

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

European Funds

Start	Project	EU co-financing	Programme
2018-05-07	Opracowanie polskiego leku stosowanego w terapii schorzeń ogólnych bakteryjnych u psów i kotów – badania technologiczne.	$66,937$66,937	Program Operacyjny Inteligentny Rozwój

Tenders

No recorded participation in tenders.

Authorized Representatives

Monika Jezierska – President of the Management Board

Monika Marczak – Management Board Member

Manner of representation

In the case of a one-person management board: one member of the management board; in the case of a multi-member management board: the President of the Management Board jointly with one member of the management board.

Ownership

Owner	Shares	Share value	Stake
Monika Jezierska (58)	50	$675.31	50%
Monika Marczak (58)	50	$675.31	50%

Beneficial owners

No beneficial owners recorded for the company Celvet.

Competitors

Name	Revenue	Website
BiotonS.A.	$72,911,351.08	bioton.com
Celon PharmaS.A.	$52,550,739.16	celonpharma.com
VercoS.A.	$43,577,172.02	verco.com.pl
VipharmS.A.	$30,660,173.61	vipharm.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com

FAQ

Last updated: 2026-04-28